Biotech Catches Major Premarket Bid Following FDA Approval
04 April 2024 - 1:25AM
AllPennyStocks.com
A Washington D.C.-based biotech is causing
quite the stir so far during Wednesday’s premarket after the
company’s Fanapt received FDA approval for the acute
treatment...
To read the full story on AllPennyStocks.com, click
here.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From May 2024 to Jun 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Jun 2023 to Jun 2024